Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level

F. F. Casanueva, L. Villanueva, C. Dieguez, J. A. Cabranes, Y. Diaz, B. Szoke, M. F. Scanlon, Andrew V Schally, A. Fernandez-Cruz

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

The role of acetylcholine (Ach) in the regulation of human GH secretion was assessed using atropine, which selectively blocks cholinergic muscarinic receptors. Paired tests were performed in seven normal subjects using GH-releasing hormone (GHRH) 1-44 (1 μg/kg iv), with and withot atropine pretreatment (1 mg im). The GHRH 1-44-induced GH secretory peak [20.7 ± 4.5 (SEM) ng/ml] was completely blocked by atropine administration (2.3 ± 0.6 ng/ml) (P < 0.01). To determine whether this atropine blockade was at the pituitary level, a series of in vitro studies were conducted using monolayer cultures of cells from bovine anterior pituitary glands. GHRH 1-44 (10-8 M) stimulated bovine GH release (11.1 ± 1.5 μg/ml) as compared to control values (5.1 ± 0.4 μg/ml) (P < 0.01). This response was not altered by 10-6 M atropine (14.9 ± 0.9 μg/ml). Similar results were obtained with GHRH, 10-9 M, with or without atropine, 10-7 M. Addition of 10-6 M Ach to the incubation medium significantly increased bovine GH release (12.7 ± 1.2 μg/ml) and the effect of 10-6 M Ach and 10-8 M GHRH was additive (20.9 ± 2.1 μg/ml) (P < 0.01). Similar results were obtained with Ach, 10-5 M, and GHRH, 10-9 M. Atropine or eserine alone did not alter basal GH secretion, and atropine blocked Ach-stimulating activity. In conclusion, atropine blockade of GHRH-induced GH secretion appears to be exerted at a site other than pituitary.

Original languageEnglish
Pages (from-to)186-191
Number of pages6
JournalJournal of Clinical Endocrinology and Metabolism
Volume62
Issue number1
StatePublished - May 1 1986
Externally publishedYes

Fingerprint

Growth Hormone-Releasing Hormone
Atropine
Growth Hormone
Acetylcholine
Hormones
Physostigmine
Anterior Pituitary Gland
Human Growth Hormone
Cholinergic Receptors
Muscarinic Receptors
Cholinergic Agents
Monolayers
Cell Culture Techniques
Scanning electron microscopy

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Casanueva, F. F., Villanueva, L., Dieguez, C., Cabranes, J. A., Diaz, Y., Szoke, B., ... Fernandez-Cruz, A. (1986). Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level. Journal of Clinical Endocrinology and Metabolism, 62(1), 186-191.

Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level. / Casanueva, F. F.; Villanueva, L.; Dieguez, C.; Cabranes, J. A.; Diaz, Y.; Szoke, B.; Scanlon, M. F.; Schally, Andrew V; Fernandez-Cruz, A.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 62, No. 1, 01.05.1986, p. 186-191.

Research output: Contribution to journalArticle

Casanueva, FF, Villanueva, L, Dieguez, C, Cabranes, JA, Diaz, Y, Szoke, B, Scanlon, MF, Schally, AV & Fernandez-Cruz, A 1986, 'Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level', Journal of Clinical Endocrinology and Metabolism, vol. 62, no. 1, pp. 186-191.
Casanueva, F. F. ; Villanueva, L. ; Dieguez, C. ; Cabranes, J. A. ; Diaz, Y. ; Szoke, B. ; Scanlon, M. F. ; Schally, Andrew V ; Fernandez-Cruz, A. / Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level. In: Journal of Clinical Endocrinology and Metabolism. 1986 ; Vol. 62, No. 1. pp. 186-191.
@article{b555f212b7c348c2a8b47fc002fe469d,
title = "Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level",
abstract = "The role of acetylcholine (Ach) in the regulation of human GH secretion was assessed using atropine, which selectively blocks cholinergic muscarinic receptors. Paired tests were performed in seven normal subjects using GH-releasing hormone (GHRH) 1-44 (1 μg/kg iv), with and withot atropine pretreatment (1 mg im). The GHRH 1-44-induced GH secretory peak [20.7 ± 4.5 (SEM) ng/ml] was completely blocked by atropine administration (2.3 ± 0.6 ng/ml) (P < 0.01). To determine whether this atropine blockade was at the pituitary level, a series of in vitro studies were conducted using monolayer cultures of cells from bovine anterior pituitary glands. GHRH 1-44 (10-8 M) stimulated bovine GH release (11.1 ± 1.5 μg/ml) as compared to control values (5.1 ± 0.4 μg/ml) (P < 0.01). This response was not altered by 10-6 M atropine (14.9 ± 0.9 μg/ml). Similar results were obtained with GHRH, 10-9 M, with or without atropine, 10-7 M. Addition of 10-6 M Ach to the incubation medium significantly increased bovine GH release (12.7 ± 1.2 μg/ml) and the effect of 10-6 M Ach and 10-8 M GHRH was additive (20.9 ± 2.1 μg/ml) (P < 0.01). Similar results were obtained with Ach, 10-5 M, and GHRH, 10-9 M. Atropine or eserine alone did not alter basal GH secretion, and atropine blocked Ach-stimulating activity. In conclusion, atropine blockade of GHRH-induced GH secretion appears to be exerted at a site other than pituitary.",
author = "Casanueva, {F. F.} and L. Villanueva and C. Dieguez and Cabranes, {J. A.} and Y. Diaz and B. Szoke and Scanlon, {M. F.} and Schally, {Andrew V} and A. Fernandez-Cruz",
year = "1986",
month = "5",
day = "1",
language = "English",
volume = "62",
pages = "186--191",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "1",

}

TY - JOUR

T1 - Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level

AU - Casanueva, F. F.

AU - Villanueva, L.

AU - Dieguez, C.

AU - Cabranes, J. A.

AU - Diaz, Y.

AU - Szoke, B.

AU - Scanlon, M. F.

AU - Schally, Andrew V

AU - Fernandez-Cruz, A.

PY - 1986/5/1

Y1 - 1986/5/1

N2 - The role of acetylcholine (Ach) in the regulation of human GH secretion was assessed using atropine, which selectively blocks cholinergic muscarinic receptors. Paired tests were performed in seven normal subjects using GH-releasing hormone (GHRH) 1-44 (1 μg/kg iv), with and withot atropine pretreatment (1 mg im). The GHRH 1-44-induced GH secretory peak [20.7 ± 4.5 (SEM) ng/ml] was completely blocked by atropine administration (2.3 ± 0.6 ng/ml) (P < 0.01). To determine whether this atropine blockade was at the pituitary level, a series of in vitro studies were conducted using monolayer cultures of cells from bovine anterior pituitary glands. GHRH 1-44 (10-8 M) stimulated bovine GH release (11.1 ± 1.5 μg/ml) as compared to control values (5.1 ± 0.4 μg/ml) (P < 0.01). This response was not altered by 10-6 M atropine (14.9 ± 0.9 μg/ml). Similar results were obtained with GHRH, 10-9 M, with or without atropine, 10-7 M. Addition of 10-6 M Ach to the incubation medium significantly increased bovine GH release (12.7 ± 1.2 μg/ml) and the effect of 10-6 M Ach and 10-8 M GHRH was additive (20.9 ± 2.1 μg/ml) (P < 0.01). Similar results were obtained with Ach, 10-5 M, and GHRH, 10-9 M. Atropine or eserine alone did not alter basal GH secretion, and atropine blocked Ach-stimulating activity. In conclusion, atropine blockade of GHRH-induced GH secretion appears to be exerted at a site other than pituitary.

AB - The role of acetylcholine (Ach) in the regulation of human GH secretion was assessed using atropine, which selectively blocks cholinergic muscarinic receptors. Paired tests were performed in seven normal subjects using GH-releasing hormone (GHRH) 1-44 (1 μg/kg iv), with and withot atropine pretreatment (1 mg im). The GHRH 1-44-induced GH secretory peak [20.7 ± 4.5 (SEM) ng/ml] was completely blocked by atropine administration (2.3 ± 0.6 ng/ml) (P < 0.01). To determine whether this atropine blockade was at the pituitary level, a series of in vitro studies were conducted using monolayer cultures of cells from bovine anterior pituitary glands. GHRH 1-44 (10-8 M) stimulated bovine GH release (11.1 ± 1.5 μg/ml) as compared to control values (5.1 ± 0.4 μg/ml) (P < 0.01). This response was not altered by 10-6 M atropine (14.9 ± 0.9 μg/ml). Similar results were obtained with GHRH, 10-9 M, with or without atropine, 10-7 M. Addition of 10-6 M Ach to the incubation medium significantly increased bovine GH release (12.7 ± 1.2 μg/ml) and the effect of 10-6 M Ach and 10-8 M GHRH was additive (20.9 ± 2.1 μg/ml) (P < 0.01). Similar results were obtained with Ach, 10-5 M, and GHRH, 10-9 M. Atropine or eserine alone did not alter basal GH secretion, and atropine blocked Ach-stimulating activity. In conclusion, atropine blockade of GHRH-induced GH secretion appears to be exerted at a site other than pituitary.

UR - http://www.scopus.com/inward/record.url?scp=0022631467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022631467&partnerID=8YFLogxK

M3 - Article

C2 - 3079600

AN - SCOPUS:0022631467

VL - 62

SP - 186

EP - 191

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 1

ER -